GlassScriptPhysician profile
Jane Cary Burns
NPI 1619040953
$1,962.30
in general payments reported to CMS, 2019-2025
14 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2021: $459 · 2022: $400 · 2023: $145 · 2024: $161 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $479.43 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $255.59 | 2023-2025 | Camzyos |
| Shockwave Medical, INC | $177.62 | 2021 | |
| Cathworks, INC. | $151.52 | 2019 | |
| Amgen INC. | $128.08 | 2019-2024 | Repatha |
| W. L. Gore & Associates, INC. | $126.81 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Boston Scientific Corporation | $124.93 | 2019 | |
| Philips North America LLC | $122.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $118.28 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $100.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.00 | 2021 | |
| Samsung Hme America, INC. | $50.00 | 2022 | |
| Menarini Silicon Biosystems, INC. | $26.47 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.